Open company graph database — free web & API
Login

Pharmaceutical Company

製薬会社
Ticker
—
Listed market
—
Country
Japan
Employees (consolidated)
1,479
Related companies
6
§01

Basic information

BASIC
Head office
160-8515 Tokyo, Shinjuku-ku Yotsuya 1-7
Chief executive
Naoyuki Mochida
Capital
7,229,000,000  (72 100 million)
Employees (non-consolidated)
Employees (consolidated)
1,479 people
Start date
1945-04-28
End date
§02

Websites

1 DOMAINS
§03

Business

4
Sale and import/export of pharmaceuticals and related productsPharmaceutical-related businessBiomaterials businessHealthcare business
§04

Related companies

6 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Mochida Medical USA, Inc.
Group Subsidiary
Mochida Heartful Service Co., Ltd.
Group Subsidiary
Mochida Healthcare Co., Ltd.
Group Subsidiary
Mochida Pharmaceutical Sales Co., Ltd.
Group Subsidiary
TechnoFine Corporation
Group Subsidiary
Mochida Pharmaceutical Plant Co., Ltd.
Group Subsidiary
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

58 EVENTS

FoundedSources

EstablishedSources

Launch of pregnancy diagnostic reagent "Gonastick 25"Sources

Launch of antiviral cream "Arasena-A Cream 3%"Sources

Ota-Hara Factory ISO 14001 Certification ObtainedSources

Launch of health and beauty supplement "Vitacolage"Sources

Launch of G n R H derivative formulation "Sprayquar"Sources

Start of sales for Mochida Medical Systems Co., Ltd. (medical device division spun off)Sources

Launch of hemostatic agent "Thrombine Liquid Motida Soft Bottle"Sources

Launch of basic cosmetics "Collage S Cosmetic Series"Sources

Start of sales for Mochida Healthcare Co., Ltd. (healthcare division spun off)Sources

Start of sales for Mochida Siemens Medical Systems Co., Ltd.Sources

Launch of EPA formulation "Epadeal S900" stick packagingSources

Mochida Pharmaceutical Factory Co., Ltd. Commences OperationsSources

Results of large-scale trial "JELIS" of "Epadeal" announced by the American Heart Association (AHA)Sources

First Japanese sensitive skin whitening series "Collage Whitening Series" releasedSources

"Collage Full Full Liquid Soap" releasedSources

First Japanese condyloma acuminatum treatment drug "Besselna" releasedSources

Joint promotion of antihypertensive drug "Diovan" started (ended December 2008)Sources

Uterine fibroid treatment drug "Dinagest" releasedSources

Enzyme-infused powdered cleanser "Collage White Peel" launchSources

Transdermal estradiol formulation "Divigel" launchSources

Antifungal shampoo and conditioner "Collage Full Full Next" launchSources

Pregnancy diagnostic aid reagent "Gonastick W" launchSources

Antidepressant "Lexapro" launchSources

Rapid-acting postprandial glucose-lowering agent "Fastick" launchSources

Specific health food (Tokho) "Glucorina" launchSources

Switch OTC drug "Epadeal" launchSources

"Collage B.K.AGE Series" launchSources

Biologic similar "Filgrastim BS "Motida"" launchSources

Chronic pain/after-extraction pain treatment drug "Tramset" tablet launchSources

Mochida Pharmaceutical Sales Co., Ltd. Commences OperationsSources

Hypertension treatment drug "Ateedio" tablet launchSources

"Collage Cosmetics Series" renewal launchSources

Pulmonary arterial hypertension treatment drug "Treprostol" launchSources

Ulcerative colitis treatment drug "Realda" launchSources

Extracorporeal diagnostic drug for ulcerative colitis "Carprotection Motida" launchSources

Antineoplastic agent "Doxil" launchSources

Chronic constipation treatment drug "Gufis" launchSources

Biologic similar "Etanercept BS "MA"" launchSources

"Collage Full Full Premium Shampoo" launchSources

Release of chronic constipation treatment drug "Mobicol"Sources

Release of "Collage Repair Series"Sources

Release of biosimilar "Teriparatide BS "Motida"Sources

Release of pregnancy diagnostic aid reagent "Gonacard W"Sources

Release of gout and hyperuricemia treatment drug "Yuris"Sources

Release of dysmenorrhea treatment drug "Dinagest tablets 0.5 mg"Sources

Release of biosimilar "Adalimumab BS "MA"Sources

Transition to Tokyo Stock Exchange Prime MarketSources

Completion and commencement of operations at new headquarters building (Yotsuya)Sources

Release of self-emulsifying high-purity EPA formulation "Epadeal EM"Sources

Release of ulcerative colitis treatment drugs "Onbo" and "Colichment"Sources

Release of biosimilar "Pegfilgrastim BS subcutaneous injection "Motida"Sources

Neural Regeneration Inducing Material "ReFeel" Released (USA)Sources

Mochida Medical USA, Inc. Commences OperationsSources

Release of cartilage repair material "Motijel"Sources

Release of high-purity EPA formulation "Eicosapentaenoic acid ethyl granule capsule "Motida"Sources

Release of "Collage Full Full Plus Series"Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑